PXR antagonists (Albert Einstein College of Medicine/FCCDC)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePXR antagonists (Albert Einstein College of Medicine/FCCDC)
Drug Alias NamePXR antagonists (FCCDC)FLB-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPregnane X receptor inhibitors
TargetsPregnane X receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbert Einstein College Of Medicine IncFox Chase Chemical Diversity Center Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A